Emcure Pharmaceuticals Limited (BOM:544210)
India · Delayed Price · Currency is INR 1,916.80
-5.60 (-0.29%)
At close: Oct 7, 2026
Emcure Pharmaceuticals Market Cap
Emcure Pharmaceuticals has a market cap or net worth of 363.58 billion as of October 7, 2026. Its market cap has increased by 33.63% in one year.
Market Cap
363.58B
Enterprise Value
377.58B
Revenue
96.83B
Ranking
n/a
PE Ratio
36.05
Stock Price
1,916.80
ChartMarket Cap Chart
Since July 10, 2024, Emcure Pharmaceuticals's market cap has increased from 256.95B to 363.58B, an increase of 41.50%. That is a compound annual growth rate of 16.73%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 7, 2026 | 363.58B | 40.56% |
| Dec 31, 2025 | 258.67B | -5.64% |
| Dec 31, 2024 | 274.13B | 6.68% |
| Jul 10, 2024 | 256.95B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Dr. Reddy's Laboratories | 999.66B |
| Lupin | 927.73B |
| Abbott India | 570.16B |
| GlaxoSmithKline Pharmaceuticals | 470.02B |
| J. B. Chemicals & Pharmaceuticals | 387.31B |
| Granules India | 203.39B |
| Caplin Point Laboratories | 200.09B |
| Jubilant Pharmova | 158.49B |